Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 30;23(1):46.
doi: 10.1186/s12955-025-02371-1.

Mapping the ADDQoL to the EQ-5D-5L and SF-6Dv2 among Chinese patients with type 2 diabetes mellitus

Affiliations

Mapping the ADDQoL to the EQ-5D-5L and SF-6Dv2 among Chinese patients with type 2 diabetes mellitus

Haoran Fang et al. Health Qual Life Outcomes. .

Abstract

Objective: The Audit of Diabetes-Dependent Quality of Life (ADDQoL) is a widely used instrument for assessing quality of life in Type 2 Diabetes Mellitus (T2DM). However, it does not directly yield health utility values essential for economic evaluations. This study developed mapping algorithms to predict EQ-5D-5L and SF-6Dv2 utility values from ADDQoL scores in T2DM patients in China.

Methods: Cross-sectional data from 800 T2DM patients in China, stratified by age, sex, and geographical region, were divided into development (80%) and validation (20%) groups. Pearson correlation analyses were conducted to assess the conceptual overlap between ADDQoL and the EQ-5D-5L and SF-6Dv2. Six predictor sets and six regression methods were explored to map ADDQoL scores to EQ-5D-5L and SF-6Dv2 utility values, respectively. Model performance was evaluated using mean absolute error (MAE), root mean square error (RMSE), and intraclass correlation coefficient (ICC).

Results: For the development group, the mean (SD) ADDQoL Average Weighted Impact (AWI) score was - 2.426 (1.052), and the mean (SD) utility values for EQ-5D-5L and SF-6Dv2 were 0.928 (0.092) and 0.791 (0.133), respectively. Among all 36 alternative mapping models each for EQ-5D-5L and SF-6Dv2, the best performance was consistently observed in the two-part models that included the ADDQoL AWI, the first overview item, and their squared terms. For the algorithm mapping to EQ-5D-5L utility values, it achieved a MAE of 0.067, a RMSE of 0.095, and an ICC of 0.414; For the algorithm mapping to SF-6Dv2 utility values, the corresponding metrics were an MAE of 0.099, an RMSE of 0.120, and an ICC of 0.517.

Conclusions: This study provides a mapping framework to estimate EQ-5D-5L and SF-6Dv2 utility values from ADDQoL scores. These algorithms could be used to support economic evaluations, specifically tailored for Chinese T2DM populations.

Keywords: ADDQoL; EQ-5D-5L; HRQoL; Mapping; SF-6Dv2; Type 2 diabetes mellitus.

PubMed Disclaimer

Conflict of interest statement

Declarations. Role of the funder: The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. Conflicts of interest/competing interests: No conflicts of interest were reported by the authors. Consent to participate: Informed consent was obtained from all individual participants included in the study. Participants were informed about their freedom of refusal. Anonymity and confidentiality were maintained throughout the research process. Ethical approval: This study was approved by the Academic Ethics Committee at Tianjin University (No. TJUE-2023-206) and was conducted in accordance with the Declaration of Helsinki.

Figures

Fig. 1
Fig. 1
Distribution of the EQ-5D-5L and the SF-6Dv2 utility value (N = 800). (a) The distribution of the EQ-5D-5L utility value (N = 800). (b) The distribution of the SF-6Dv2 utility value (N = 800)
Fig. 2
Fig. 2
The optimal model performance is mapped onto the utility values of EQ-5D-5L and SF-6Dv2 in validation group (N = 160)

Similar articles

Cited by

References

    1. Kudabayeva K, Tleumagambetova B, Bazargaliyev Y, Kosmuratova R, Zhylkybekova A. Global Trends in LADA Type Diabetes Research: A Bibliometric Analysis of Publications from Web of Science and Scopus, 1994–2024. J Diabetes Res. 2024;2024:4960075. - PMC - PubMed
    1. Worldwide trends in. Diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants. Lancet. 2024;404(10467):2077–93. - PMC - PubMed
    1. IDF Diabetes Atlas. 10th edn [https://www.diabetesatlas.org]
    1. Hong SN, Mak IL, Chin WY, Yu EYT, Tse ETY, Chen JY, Wong CKH, Chao DVK, Tsui WWS, Lam CLK, et al. Age-specific associations between the number of co-morbidities, all-cause mortality and public direct medical costs in patients with type 2 diabetes: A retrospective cohort study. Diabetes Obes Metab. 2023;25(2):454–67. - PubMed
    1. He X, Zhang Y, Zhou Y, Dong C, Wu J. Direct medical costs of incident complications in patients newly diagnosed with type 2 diabetes in China. Diabetes Ther. 2021;12(1):275–88. - PMC - PubMed

Supplementary concepts

LinkOut - more resources